The impact of amniotic fluid volume assessed intrapartum on perinatal outcome.
OBJECTIVE
Our purpose was to determine the value of routine intrapartum amniotic fluid volume assessment on perinatal outcome.


METHODS
Patients admitted for labor and delivery who were ultimately delivered between January 1988 and June 1989 with a gestational age > or = 26 weeks and who had an intrapartum amniotic fluid index composed the study group. The amniotic fluid index was determined by the four-quadrant technique on admission to labor and delivery. Oligohydramnios was defined as an amniotic fluid index < or = 5 cm (n = 170), borderline oligohydramnios as an amniotic fluid index 5.1 to 8.0 cm (n = 261), and normal amniotic fluid volume as an amniotic fluid index 8.1 to 20 cm (n = 336). Nine patients with an amniotic fluid index > 20 cm were excluded from data analysis. The oligohydramnios and borderline oligohydramnios groups were compared with the normal group with regard to antenatal, intrapartum, and postpartum variables.


RESULTS
The groups had similar maternal age, parity, gestational age at delivery, and antenatal complications. Meconium-stained amniotic fluid occurred significantly less often in the oligohydramnios group compared with the normal group (relative risk 0.67, 95% confidence interval 0.49 to 0.92). However, variable decelerations occurred significantly more often in the oligohydramnios group compared with the normal group (relative risk 1.44, 95% confidence interval 1.12 to 1.87), and cesarean delivery for fetal distress also occurred significantly more often (relative risk 6.83, 95% confidence interval 1.55 to 30.4). There was no difference in Apgar scores or neonatal complications between groups. The efficacy of intrapartum-determined oligohydramnios predicting cesarean delivery for fetal distress gave a sensitivity of 78%, a specificity of 74%, a positive predictive value of 33%, and a negative predictive value of 95%.


CONCLUSIONS
The amniotic fluid index for detecting intrapartum oligohydramnios is a valuable screening test for subsequent fetal distress requiring cesarean delivery.
Baron
C
C
Department of Obstetrics and Gynecology, University of California, Irvine, Orange, USA.
Morgan
M A
MA
Garite
T J
TJ
D000653:Amniotic Fluid; D001034:Apgar Score; D003955:Diagnostic Tests, Routine; D005260:Female; D005316:Fetal Distress / Q000209:etiology; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000209:etiology; D007743:Labor, Obstetric; D008423:Maternal Age; D016104:Oligohydramnios / Q000175:diagnosis*; D010298:Parity; D011247:Pregnancy; D011248:Pregnancy Complications / Q000209:etiology; D011256:Pregnancy Outcome; D012680:Sensitivity and Specificity